Abbott Laboratories (ABT) Revenue Growth (5y) (2014 - 2026)
Abbott Laboratories (ABT) Revenue Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.35 Bn | 180.06 Bn | 6.27 Bn |
| 2 | Stryker | 132.18 Bn | 129.31 Bn | 3.81 Bn |
| 3 | Medtronic | 111.47 Bn | 102.25 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.97 Bn | 67.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.83 Bn | 1.29 Bn |
| 6 | Dexcom | 29.00 Bn | 27.88 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.78 Bn | 26.49 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 28.00 Bn | 27.42 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.22 Bn | 2.01 Bn |
| 10 | Steris | 22.33 Bn | 21.89 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32% |
| Dec 31, 2025 | 1.38% |
| Sep 30, 2025 | 5.13% |
| Jun 30, 2025 | 8.74% |
| Mar 31, 2025 | 6.04% |
| Dec 31, 2024 | 5.71% |
| Sep 30, 2024 | 5.66% |
| Jun 30, 2024 | 5.40% |
| Mar 31, 2024 | 5.75% |
| Dec 31, 2023 | 5.69% |
| Sep 30, 2023 | 5.79% |
| Jun 30, 2023 | 5.14% |
| Mar 31, 2023 | 5.69% |
| Dec 31, 2022 | 5.86% |
| Sep 30, 2022 | 8.80% |
| Jun 30, 2022 | 11.15% |
| Mar 31, 2022 | 13.43% |
| Dec 31, 2021 | 16.55% |
| Sep 30, 2021 | 15.56% |
| Jun 30, 2021 | 13.90% |